Talat Tayyaba
Child & Adolescent Psychiatry · Richardson, TXNPI 1467541664
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.0% of the total. Reporting peaked in 2022 at $982 and has fallen 98.1% since, to $19 in 2025.
Across 186 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$731
- Tris Pharma Inc$517
- Takeda Pharmaceuticals U.S.A., Inc.$313
- Supernus Pharmaceuticals, Inc.$224
- Ironshore Pharmaceuticals Inc.$199
- Corium, LLC$170
- plus $887 from 13 others
What the payments were for
- Food & beverage$3,01399%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $731 |
| Tris Pharma Inc | 38 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $313 |
| Supernus Pharmaceuticals, Inc. | 15 | $224 |
| Ironshore Pharmaceuticals Inc. | 10 | $199 |
| Corium, LLC | 8 | $170 |
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| Eisai Inc. | 7 | $145 |
| Johnson & Johnson | 7 | $113 |
| Lundbeck LLC | 5 | $101 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $96 |
| Sunovion Pharmaceuticals Inc. | 3 | $62 |
| Validus Pharmaceuticals LLC | 2 | $51 |
| Shire North American Group Inc | 2 | $41 |
| Adlon Therapeutics L.p. | 2 | $30 |
| Alkermes, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
How this compares
$3,041 in reported general payments places this provider in the 85th percentile of 301 child & adolescent psychiatry providers in Texas.
Other child & adolescent psychiatry in Richardson
- Alain KaticBellaire$106K
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- John SteffekSpring$14K
- Robert MosquedaEdinburg$13K
- Gloria BrunGreenville$10K
- Mudassar TariqSugar Land$9K
- Charles PryzantDallas$9K
- Mehvesh AfrinaPlano$8K
- Kishore SunkaraHurst$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.